Skip to main content
. 2025 Oct 28;22(6):1061–1068. doi: 10.21873/cgp.20555

Figure 4.

Figure 4

Kaplan–Meier survival plots of patients with pancreatic adenocarcinoma with higher ANLN levels. The overall survival analysis of patients with PAAD according to ANLN expression was performed by using the UALCAN platform. The overall survival curve of patients with PAAD was compared between a high ANLN expression group (▲, n=45) and a low/medium DDX39 expression group (n=132). p<0.05 was regarded as statistically significant. ANLN: Anillin actin-binding protein; PAAD: pancreatic adenocarcinoma; UALCAN: University of Alabama at Birmingham Cancer Data Analytics Portal.